One study showed that, SCH79797, which is an inhibitor of PAR1, blunted ERK1/2 phosphorylation, TGF-β and type I pro-collagen production and myofibroblasts transformation in isolated CFs [44]. Here, TGFB1 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.